Deshidratación

Allicin is the main bioactive sulfur-containing compound in garlic credited with antimicrobial effects against UTI-causing bacteria including E. coli. In vitro studies demonstrate strong antibacterial activity against multiple uropathogens including antibiotic-resistant strains. By reducing uropathogen load in the urinary tract, allicin supports the ecological balance that allows beneficial Lactobacillus species to maintain urinary flora health. The VA Whole Health Library includes garlic/allicin among agents with evidence against urinary pathogens.

Berberine is a plant alkaloid (from goldenseal, barberry, and related species) with documented anti-adhesive and antimicrobial effects relevant to urinary flora. It disrupts bacterial membranes and may inhibit E. coli adhesion to bladder epithelium. Clinical studies combining berberine with arbutin and D-mannose showed significantly reduced bacterial load in urinary samples and lower recurrence of cystitis compared to proanthocyanidin-only treatment. Research also suggests berberine acts as a prebiotic indirectly supporting beneficial gut bacteria.

Bifidobacterium species contribute to urinary flora support primarily through gut-urinary axis modulation, reducing the gut reservoir of uropathogens such as E. coli that ascend to cause UTIs. An 18-month RCT in 181 children found that a multi-strain probiotic including Bifidobacterium bifidum and B. lactis achieved UTI-free survival in 96.7% vs. 83.3% in placebo (p=0.02). Bifidobacterium is the most common genus in the pre-toilet-training female urinary microbiome.

Bifidobacterium animalis subsp. lactis (strain BLC1) was one component of an oral probiotic (ProBalans) shown in a 2024 clinical study to improve UTI treatment outcomes when combined with antibiotics, compared to antibiotics alone, per a Frontiers review (2025). It supports urinary flora primarily through gut-urinary axis effects, reducing uropathogen load in the intestinal reservoir.

Bifidobacterium bifidum was a component of the multi-strain probiotic that demonstrated significantly improved UTI-free survival in a double-blind RCT in 181 children with febrile UTI (96.7% vs. 83.3%, p=0.02). It supports urinary flora indirectly through gut-urinary axis effects, reducing uropathogen reservoir in the gut. It is included in clinically studied urogenital probiotic formulations.

Bifidobacterium breve is recognized among Bifidobacterium species with documented relevance to urinary tract health through gut-urinary axis modulation. Cleveland Clinic lists it among the Bifidobacterium genus noted for urinary and vaginal tract health support. It reduces gut uropathogen reservoirs and modulates immune responses relevant to UTI prevention.

Bifidobacterium lactis was a component of the multi-strain probiotic in the 18-month double-blind RCT (181 children with febrile UTI) that achieved UTI-free survival in 96.7% vs. 83.3% placebo (p=0.02). It supports urinary flora through gut-urinary axis mechanisms — reducing the intestinal uropathogen reservoir and modulating immune responses relevant to urinary tract defense.

Bifidobacterium longum is among the Bifidobacterium species with recognized roles in gut-urinary axis protection. It supports urinary flora indirectly by reducing the gut reservoir of uropathogens and modulating systemic immune responses relevant to UTI susceptibility. Cleveland Clinic includes it among Bifidobacterium species with documented relevance to urinary and vaginal tract health.

Cranberry is among the most studied natural interventions for urinary tract health, used traditionally for centuries and supported by multiple clinical trials. Its proanthocyanidins (PACs) prevent uropathogen adhesion to the urinary epithelium, protecting the natural urinary flora balance. A placebo-controlled trial found a 39% reduction in UTI symptoms with 24-week cranberry supplementation. Cochrane review and multiple meta-analyses support cranberry for UTI prevention, particularly in recurrent-UTI populations.

Fructooligosaccharides (FOS) are prebiotic fibers that selectively promote growth of beneficial Lactobacillus and Bifidobacterium species in the gut, which is the primary reservoir for uropathogens causing UTIs. By enriching beneficial flora in the gut, FOS supports the gut-urinary axis to reduce uropathogen ascension and indirectly maintain healthy urinary flora. FOS is used as a synbiotic component alongside Lactobacillus probiotics in urogenital health formulations.

Garlic has a long history of traditional medicinal use against urinary infections, supported by in vitro and some clinical evidence. Its active compound allicin demonstrates strong antibacterial effects against UTI-causing bacteria. The VA Whole Health Library includes garlic among anti-infective, anti-inflammatory agents with evidence against urinary pathogens. By suppressing uropathogen colonization, garlic supports urinary flora balance favoring beneficial Lactobacillus species.

Inulin is a prebiotic fiber that selectively promotes Bifidobacterium and Lactobacillus growth in the gut — species central to the gut-urinary axis pathway that reduces uropathogen reservoir and supports urinary flora health. By enriching beneficial gut bacteria, inulin indirectly supports the balance of urinary microflora. Inulin is used in synbiotic formulations with urogenital probiotics to sustain Lactobacillus and Bifidobacterium populations relevant to urinary tract protection.

Lactiplantibacillus plantarum (formerly Lactobacillus plantarum) is the current taxonomic name for the species documented in vaginal Döderlein flora and urinary microbiome research. In vitro studies confirm it inhibits E. coli adhesion to urinary epithelial cells through competition, inhibition, and displacement, and L. plantarum PXN47 induces mucin production in urinary epithelium. Clinical study in children with recurrent UTIs showed trend toward reduced UTI frequency with oral L. plantarum supplementation.

Lactobacillus acidophilus is a constituent of the vaginal Döderlein flora (which is directly connected to urinary flora) and is naturally present in the urinary tract. An 18-month RCT in 181 children with febrile UTI demonstrated that a multi-strain probiotic including L. acidophilus significantly improved UTI-free survival versus placebo (96.7% vs. 83.3%, p=0.02). L. acidophilus maintains urinary flora balance by acidifying the environment and inhibiting uropathogen colonization.

Lactobacillus brevis is listed among the Lactobacillus species of the vaginal Döderlein flora that is directly connected to the female urinary microbiome. MDPI Life Sciences (2023) identifies it as part of the fertile-age vaginal microbial community whose health is linked to urinary tract protection. It contributes through acidification and competitive exclusion mechanisms common to urogenital Lactobacillus species.

Lactobacillus casei is a member of the vaginal Döderlein flora with documented urinary tract relevance. Early animal studies showed indigenous L. casei strains could prevent UTI in rats. More recently, oral probiotic containing L. casei BGP93 combined with L. acidophilus and Bifidobacterium animalis was shown to improve UTI treatment outcomes when combined with antibiotics compared to antibiotics alone. European urological guidelines list L. casei strain Shirota among recommended probiotics for recurrent UTI prevention.

Lactobacillus crispatus is one of the four dominant species in the female bladder microbiome and is strongly associated with urinary tract health. Scientific research demonstrates it protects against uropathogenic E. coli by triggering type I interferon responses in bladder epithelial cells. Women with recurrent UTIs have markedly reduced bladder populations of L. crispatus compared to healthy controls. The European Association of Urology specifically recommends L. crispatus CTV-05 for prevention of recurrent UTIs.

Lactobacillus delbrueckii is one of the eight Lactobacillus species consistently identified in the female urinary microbiome using enhanced urine culture techniques. Frontiers in Cellular and Infection Microbiology (2022) notes L. delbrueckii among urinary Lactobacillus isolates, where it demonstrates in vitro inhibitory activity against major uropathogens. Its presence in Lactobacillus-dominated urobiomes is associated with lower urinary tract symptom burden.

Lactobacillus fermentum is part of the vaginal Döderlein flora that directly influences urinary flora composition. It is noted in urogenital microbiome studies and was the original classification of the L. reuteri RC-14 strain proven in urogenital RCTs. In vitro studies demonstrate L. fermentum strains exhibit potent anti-adhesive properties against uropathogenic E. coli through competition, inhibition, and displacement, suggesting a protective role for urinary flora.

Lactobacillus gasseri is one of four Lactobacillus species predominant in the female bladder microbiome, identified as a core member of the urobiome in multiple 16S rRNA sequencing studies. It is associated with probiotic capabilities including inhibition of uropathogens and maintenance of acidic urinary pH. It is included in clinical trial formulations (e.g., ASTARTE) targeting the composition of urinary bacteria to reduce recurrent UTI risk.

Lactobacillus helveticus is included in the probiotic significance literature for urogenital health, recognized among the highly regarded probiotic Lactobacillus species with documented roles in the urinary and gastrointestinal tract flora. A PMC review (2024) lists it among recognized probiotic Lactobacillus strains with impacts on the urinary microbiome. It contributes to urinary flora balance through lactic acid production and antimicrobial activity.

Lactobacillus jensenii is a core member of the female urobiome, consistently identified in healthy women's bladder and vaginal microbiomes. It is considered a regulator of the urinary microbial community, creating an acidic environment that restricts uropathogen growth. It is one of the four most prevalent Lactobacillus species in the bladder and is included in clinical trials targeting urinary flora restoration.

Lactobacillus johnsonii is one of the eight Lactobacillus species consistently found in the urinary microbiome using enhanced culture techniques. Frontiers in Cellular and Infection Microbiology (2022) identified it among urinary Lactobacillus isolates tested for inhibitory activity against uropathogens. Its presence in Lactobacillus-dominated urobiomes is associated with urinary health.

Lactobacillus paracasei is listed among recognized probiotic Lactobacillus strains with documented roles in the urinary microbiome and is identified in the vaginal Döderlein flora connected to urinary tract health. It is noted in Frontiers Cellular and Infection Microbiology (2025) as a urogenitally relevant probiotic organism. In vitro studies support its role in inhibiting uropathogens through competitive exclusion and antimicrobial compound production.

Lactobacillus plantarum is a constituent of vaginal Döderlein flora and has been studied for urinary flora support via inhibition of uropathogen adhesion. In vitro studies confirm it inhibits E. coli adhesion to vaginal and urinary epithelial cells through competition and displacement. A pilot study in children with recurrent UTIs using oral L. plantarum PM1 showed reduced UTI frequency. L. plantarum PXN47 demonstrated antibacterial activity against E. coli and induced mucin production in urinary epithelial cells.

Lactobacillus reuteri (particularly strain RC-14, formerly fermentum RC-14) is recommended by the European Association of Urology for prevention of recurrent UTIs. In RCTs, oral L. reuteri RC-14 combined with L. rhamnosus GR-1 restored Lactobacillus-dominated vaginal and urinary microbiota and reduced recurrent UTI incidence. Studies confirm that species-specific PCR demonstrates that orally administered L. reuteri RC-14 ascends to restore the urogenital flora.

Lactobacillus rhamnosus (particularly strain GR-1) is one of the most evidence-supported probiotic strains for urinary flora support, specifically recommended by the European Association of Urology for recurrent UTI prevention. Oral supplementation with L. rhamnosus GR-1 has been shown in RCTs to restore Lactobacillus populations in the vaginal and urinary microbiome and reduce recurrent UTI incidence. L. rhamnosus secretes immunomodulatory proteins in bladder cells and inhibits UPEC virulence and biofilm formation.

Lactobacillus salivarius is identified as a component of vaginal Döderlein flora that is linked to urinary tract health. MDPI Life Sciences (2023) includes it among core Lactobacillus species in fertile-age vaginal flora, which is directly connected to the urinary microbiome. It appears in multi-strain urogenital probiotic formulations studied for recurrent UTI prevention, contributing through lactic acid production and competitive exclusion of uropathogens.

D-Mannose (mannose) is a naturally occurring monosaccharide excreted in urine that prevents uropathogenic E. coli from adhering to urinary epithelium by saturating the FimH adhesin on type I pili. This anti-adhesion mechanism protects the urinary flora balance by preventing pathogen colonization. A 2022 updated Cochrane-based systematic review and multiple RCTs support D-mannose for prevention of recurrent UTIs, with one key trial showing comparable efficacy to nitrofurantoin prophylaxis.

Unlike antibiotics, methenamine exerts its antimicrobial effect exclusively within the bladder and does not appear to disrupt the indigenous urogenital flora. A small clinical study showed methenamine hippurate treatment did not influence the normal lower urogenital tract microbiota. Methenamine has also been limitedly studied as a means of preserving urinary microbial diversity compared to antibiotic prophylaxis.

Saccharomyces boulardii is a beneficial yeast probiotic with documented effects on gut microbiome composition. By reducing intestinal uropathogen populations (particularly E. coli) via the gut-urinary axis, it indirectly supports urinary flora health. It is included in probiotic formulations for microbiome restoration and is used clinically to restore gut flora following antibiotic treatment — antibiotic disruption of gut flora is a key driver of increased UTI susceptibility.

2'-Fucosyllactose (2'-FL) is a human milk oligosaccharide with recognized prebiotic properties that selectively promotes Bifidobacterium and other beneficial bacteria. While primary evidence relates to gut microbiome modulation, the gut-urinary axis connects intestinal Bifidobacterium and Lactobacillus populations to urinary flora health, as the gut is the reservoir for most UTI-causing E. coli. Use in urinary flora support is indirect and emerging.

Bearberry (uva ursi, Arctostaphylos uva-ursi) is a traditional urinary antiseptic used for centuries in European and North American folk medicine to treat urinary tract conditions. Its active compound arbutin is hydrolyzed in alkaline urine to hydroquinone, which inhibits pathogenic bacteria in the urinary tract. Leaf extracts have been approved for urinary tract inflammation by German regulatory authorities, though modern clinical trial evidence remains limited.

Bifidobacterium infantis is documented in the female urinary microbiome literature as part of the Bifidobacterium genus relevant to urinary tract health. Its use in urogenital probiotic preparations traditionally derives from its role as a beneficial infant intestinal bacterium with systemic protective properties that extend to urinary flora maintenance via gut-urinary axis modulation.

Goldenseal (Hydrastis canadensis) is a traditional North American herb used for urinary tract infections and has been used historically as an antimicrobial for urinary conditions. Its active compound berberine disrupts bacterial membranes and inhibits E. coli adhesion to bladder epithelium, potentially supporting urinary flora balance. It is included in integrative protocols for UTI management, though dedicated RCT evidence is limited.

Lactobacillus pentosus is among the Lactobacillus species recognized in the urogenital probiotic literature as supporting urinary and vaginal flora. It is included in patent literature for urogenital flora enhancement alongside other established urogenital Lactobacillus strains. Its traditional role in fermented foods with probiotic properties has led to inclusion in multi-strain preparations targeting urogenital health.